Evidence map›Paper›PMID 39083542›Full record

ArticlePloS one2024

Exploration of alive-and-ventilator free days as an outcome measure for clinical trials of Resuscitative interventions.

Ari Moskowitz, Xianhong Xie, Michelle Ng Gong, Henry E Wang, Luke Andrea, Yungtai Lo, Mimi Kim, Hospital Airway Resuscitation Trial Investigators

Abstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ari MoskowitzDivision of Critical Care Medicine, Montefiore Medical Center, The Bronx, NY, United States of America.ORCID https://orcid.org/0009-0003-5223-3121
Xianhong XieDepartment of Epidemiology and Population Health, Einstein Medical School, the Bronx, New York, United States of America.
Michelle Ng GongDivision of Critical Care Medicine, Montefiore Medical Center, The Bronx, NY, United States of America.
Henry E WangDepartment of Emergency Medicine, The Ohio State University, Columbus, Ohio, United States of America.
Luke AndreaDivision of Critical Care Medicine, Montefiore Medical Center, The Bronx, NY, United States of America.
Yungtai LoDepartment of Epidemiology and Population Health, Einstein Medical School, the Bronx, New York, United States of America.
Mimi KimDepartment of Epidemiology and Population Health, Einstein Medical School, the Bronx, New York, United States of America.
Hospital Airway Resuscitation Trial Investigators

Funding

Einstein-Montefiore Clinical and Translational Science Award HubUM1TR004400 · NCATS · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI Jessica Kahn, Mimi Y Kim · 2023 to 2026
$17.3M
Hospital Airway Resuscitation TrialR33HL162980 · NHLBI · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI Ari Moskowitz · 2023 to 2026
$3.3M
NCATS NIH HHS UM1 TR004400NHLBI NIH HHS R33 HL162980
6 · The paper itself

Abstract

backgroundOutcome selection is a critically important aspect of clinical trial design. Alive-and-ventilator free days is an outcome measure commonly used in critical care clinical trials, but has not been fully explored in resuscitation science.

methodsA simulation study was performed to explore approaches to the definition and analysis of alive-and-ventilator free days in cardiac arrest populations. Data from an in-hospital cardiac arrest observational cohort and from the Pragmatic Airway Resuscitation Trial were used to inform and conduct the simulations and validate approaches to alive-and-ventilator free days measurement and analysis.

findingsAlive-and-ventilator-free days is a flexible outcome measure in cardiac arrest populations. An approach to alive-and-ventilator free days that assigns -1 days when return of spontaneous circulation is not achieved provides a wider distribution of the outcome and improves statistical power. The optimal approach to the analysis of alive-and-ventilator free days varies based on the expected impact of the intervention under study on rates of return of spontaneous circulation, survival, and ventilator-free survival.

conclusionsAlive-and-ventilator free days adds to the armamentarium of clinical trialists in the field of resuscitation science.

Indexed as

Heart ArrestRespiration, ArtificialCardiopulmonary ResuscitationClinical Trials as TopicHumansOutcome Assessment, Health CareResuscitation

Identifiers

PMID39083542
PMCPMC11290648

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.